Microbot Medical Inc. (MBOT) Financial Statements (2024 and earlier)

Company Profile

Business Address 25 RECREATION PARK DR SUITE 108
HINGHAM, MA 02043
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8,202,00015,492,00024,648,00031,292,0005,238,00010,787,000
Cash and cash equivalents2,442,00013,493,00019,650,00028,771,0005,238,00010,787,000
Short-term investments5,760,0001,999,0004,998,0002,521,000  
Restricted cash and investments77,00087,00084,0004,358,00025,00027,000
Prepaid expense429,000     
Deposits current assets 3,000     
Other current assets 300,000521,000286,000568,000116,000
Other undisclosed current assets103,000     
Total current assets:8,814,00015,879,00025,253,00035,936,0005,831,00010,930,000
Noncurrent Assets
Operating lease, right-of-use asset502,000644,000775,000962,000
Property, plant and equipment221,000244,000251,000228,000259,00090,000
Total noncurrent assets:723,000888,0001,026,0001,190,000259,00090,000
TOTAL ASSETS:9,537,00016,767,00026,279,00037,126,0006,090,00011,020,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,786,0001,706,0001,158,0001,079,0001,385,000528,000
Accounts payable116,000279,000275,000284,000630,00078,000
Accrued liabilities1,670,0001,427,000883,000795,000755,000450,000
Debt    143,000  
Estimated litigation liability      
Other undisclosed current liabilities283,000278,000187,0003,604,0003,375,000 
Total current liabilities:2,069,0001,984,0001,345,0004,826,0004,760,000528,000
Noncurrent Liabilities
Long-term debt and lease obligation:  402,000626,000760,000  
Liabilities, other than long-term debt179,000   8,00028,000
Operating lease, liability179,000402,000626,000760,000
Derivative instruments and hedges, liabilities     8,00028,000
Other undisclosed noncurrent liabilities  (402,000)(626,000)   
Total noncurrent liabilities:179,000402,000626,000760,0008,00028,000
Total liabilities:2,248,0002,386,0001,971,0005,586,0004,768,000556,000
Temporary equity, carrying amount      500,000
Equity
Equity, attributable to parent, including:7,289,00014,381,00024,308,00031,540,0001,322,0009,964,000
Common stock80,00072,00072,00072,00031,000406,000
Treasury stock, value    (3,375,000)(3,375,000)(500,000)
Additional paid in capital75,970,00069,902,00068,516,00069,954,00032,530,00030,182,000
Accumulated deficit(68,761,000)(55,593,000)(44,280,000)(35,111,000)(27,864,000)(20,624,000)
Other undisclosed equity, attributable to parent      500,000
Total equity:7,289,00014,381,00024,308,00031,540,0001,322,0009,964,000
TOTAL LIABILITIES AND EQUITY:9,537,00016,767,00026,279,00037,126,0006,090,00011,020,000

Income Statement (P&L) (USD)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Operating expenses(13,281,000)(11,357,000)(9,089,000)(7,240,000)(7,244,000)5,267,000
Other undisclosed operating income (loss)     14,488,000(10,534,000)
Operating income (loss):(13,281,000)(11,357,000)(9,089,000)(7,240,000)7,244,000(5,267,000)
Nonoperating expense (5,000)   (14,000) 
Loss, foreign currency transaction, before tax     (14,000) 
Other nonoperating expense (5,000)     
Interest and debt expense      2,322,000
Income (loss) from continuing operations:(13,286,000)(11,357,000)(9,089,000)(7,240,000)7,230,000(2,945,000)
Income (loss) before gain (loss) on sale of properties:(11,357,000)(9,089,000)(7,240,000)7,230,000(2,945,000)
Other undisclosed net income    14,487,00010,00010,534,000
Net income (loss):(13,286,000)(11,357,000)(9,089,000)7,247,0007,240,0007,589,000
Other undisclosed net income (loss) attributable to parent118,00044,000(80,000)(14,494,000)(14,480,000)(15,178,000)
Net loss attributable to parent:(13,168,000)(11,313,000)(9,169,000)(7,247,000)(7,240,000)(7,589,000)
Preferred stock dividends and other adjustments     (254,000)(1,582,000)
Other undisclosed net income available to common stockholders, basic    14,494,00014,480,00015,178,000
Net income (loss) available to common stockholders, basic:(13,168,000)(11,313,000)(9,169,000)7,247,0006,986,0006,007,000
Interest on convertible debt      (237,000)
Net income (loss) available to common stockholders, diluted:(13,168,000)(11,313,000)(9,169,000)7,247,0006,986,0005,770,000

Comprehensive Income (USD)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):(13,286,000)(11,357,000)(9,089,000)7,247,0007,240,0007,589,000
Comprehensive income (loss):(13,286,000)(11,357,000)(9,089,000)7,247,0007,240,0007,589,000
Other undisclosed comprehensive loss, net of tax, attributable to parent   (80,000)(14,494,000)  
Comprehensive income (loss), net of tax, attributable to parent:(13,286,000)(11,357,000)(9,169,000)(7,247,000)7,240,0007,589,000

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: